slide1 l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
IOL Chemicals and Pharmaceuticals Limited PowerPoint Presentation
Download Presentation
IOL Chemicals and Pharmaceuticals Limited

Loading in 2 Seconds...

play fullscreen
1 / 70

IOL Chemicals and Pharmaceuticals Limited - PowerPoint PPT Presentation


  • 716 Views
  • Uploaded on

IOL Chemicals and Pharmaceuticals Limited. Barnala. Geographical Location Map. Mile Stones Crossed. 1986 – IOLCP Established 1991 – Commenced Acetic Acid Production 1996 – Commissioned Ethyl Acetate Plant 1999 – Commenced Acetic Anhydride Production 2000 – Commissioned Ibuprofen Plant

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'IOL Chemicals and Pharmaceuticals Limited' - Antony


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide2

Barnala

Geographical Location Map

mile stones crossed
Mile Stones Crossed

1986 – IOLCP Established

1991 – Commenced Acetic Acid Production

1996 – Commissioned Ethyl Acetate Plant

1999 – Commenced Acetic Anhydride Production

2000 – Commissioned Ibuprofen Plant

2006 – Commissioned Power Cogeneration

product range
Product Range

Active Pharmaceutical Ingredients

Ibuprofen

Proton Pump Inhibitors (PPI’s)(Proposed)

Chemical Products

Acetic Acid

Ethyl Acetate

Acetic Anhydride

MCA & Acetyl Chloride IBB

capacity by product
Capacity By Product

Capacity ( TPA )

Acetic Acid

Ethyl Acetate

Acetic Anhydride

Ibuprofen

Products

revenues
Revenues

USD 20 mln

USD 36 mln

USD 48 mln

USD 75 mln

USD 70 mln

Years

operating profit
Operating Profit

USD 1.8 mln

USD 3.8mln

USD 3.9 mln

USD 7.7 mln

USD 7.2 mln

Years

net profit after tax
Net Profit After Tax

USD 0.53 mln

USD 1.51 mln

USD 1.57 mln

USD 2.57 mln

USD 2.64 mln

Years

export sales
Export Sales

USD 0.41 mln

USD 2.70mln

USD 4.79 min

USD 10.4 min

USD 9.16mln

Years

slide11

GROWTH - Projects Under Implementation

  • Recently increased Ibuprofen capacity from 1800 TPA to 3600 TPA .
  • Currently implementing projects for Capacity Expansions, Forward & Backward Integration & Power Cogeneration, involving a capital expenditure of Rs 256 Crores (approx USD 53.3 million).
  • Commencing a new project for the production of PPI’s i.e. Rabiprazole, Omeprazole, Pantoprazole Esomeprazole and Lansoprazole in Jan 2010 at a cost of Rs 100 Crores ( approx USD 20.83 million).
slide13

Co-generation

Expanding captive power cogeneration

capacity to 17 MW, from 4 MW currently

Present captive energy generation include

Steam and Power Generation

slide14

Monochloroacetic Acid & Acetyl ChlorideProcess Flow

Acetic Anhydride

Acetic Acid

HCl

Acetic Acid

(By Product)

Chlorine Gas

HCl (By Product)

Acetyl Chloride

MCA

slide15

Uses of Iso-Butyl Benzene

IBB PLANT

SPENTGAS

IBB

HIGH HYDRO CARBON

LOW HYDRO CARBON

POTASIUM CARBONATE

THERMO

PACK

MARKET

ACETIC

ANHY

DRIDE

CAPTIVE CONSUMP TION

CO-

GEN

ACETIC

ANHY

DRIDE

ACETIC

ANHY

DRIDE

MARKET

THERMO

PACK

MARKET

THE END PACK

REUSE IN IBB PROCESS

CO-

GEN

slide16

Projected Capacity Fiscal Year 2011-12

ALL OF THESE PROJECTS WILL HAVE TO BE FINANCED FROM INTERNAL ACCRUALS AND TERM DEBT WITHOUT FURTHER DILUTION IN EQUITY. THIS WILL RESULT IN SIGNIFICANT GROWTH IN PROFITABILITY AND EARNINGS PER SHARE

slide17

Global Market Presence

The various international markets catered till date include:

1.BANGLADESH 15.IRAN 29.SPAIN 43.ITALY

2.EGYPT 16.VEITNAM 30.PHILIPPINES 44.MAURITIUS

3.UGANDA 17.KUWAIT 31.CHILE 45.CHILE

4.SYRIA 18.GERMAN 32.ZIMBABWE 46.TAIWAN

5.AUSTRALIA 19.COLOMBIA 33.URUGUAY 47.TASMANIA

6.DUBAI 20.SINGAPORE 34.GHANA 48.OMAN

7.PAKISTAN 21.HONG KONG 35.TURKEY 49.COLOMBIA

8.THAILAND 22.MALAWI 36.CHINA 50.SOUTH AMERICA

9.MALAYSIA 23.BRAZIL 37.CONGO 51.YEMEN

10.BOLIVIA 24.SOUTH KOREA 38.SUDAN

11.MEXICO 25.PERU 39.NIGERIA

12.VENEZUELA 26.GUATEMALA 40.KENYA

13.ALGERIA 27.NEPAL 41.NEW ZEALAND

14.LATAVIA 28.DENMARK 42.SRI LANKA

ibuprofen
Non-Steroidal Anti – Inflammatory Drug (NSAID)

Reduces Hormones Causing Inflammation & Pain in Body

Usage in Treatment of Variety of Ailments

Grades Available :

- IP / BP /USP / EP /JP

- Micronized

- Dexibuprofen

- DC ( Directly compressible )

Ibuprofen
ibuprofen market share
Ibuprofen - Market Share

Domestic Market

Global Market

Indian Market

8000 MT per Annum

Global Market

25,000 MT per Annum

slide25

Acetic Acid

  • Acetic Acid or Ethanoic Acid Commonly Known as Vinegar
  • Sour Taste & Pungent Smell
  • Widely used as Chemical Reagent & Industrial Chemical
  • Derivatives application almost in all fields
slide26

Applications & End Usage –Acetic Acid

*IOLCP is Entering into the Manufacturing of MCA with the Capacity of 7200 TPA.

slide32

Acetic Acid – Market Share

Domestic Market

Global Market

Indian Market

4,50,000 MT per Annum

Global Market

92,00,000 MT per Annum

slide33

Ethyl Acetate

  • Ethyl Acetate or Ethyl Ethanoate – Fragrant, Colorless Liquid
  • Diverse Industrial Application as Solvent
  • Usage as Synthetic Fruit Essence
  • Flavor in Pharmaceuticals
  • Coextractant of Camphor, Fats, Oils & Antibiotics
  • Ability to replace Aromatic Solvents like Toulene, Xylene & Methyl Isobutyl Ketone.
slide38

Ethyl Acetate - Market Share

Domestic Market

Global Market

Indian Market

1,90,000 MT per Annum

Global Market

14,00,000 MT per Annum

slide39

Acetic Anhydride

  • Ethanoic Anhydride or Acid Anhydride
  • Declared As “Controlled Substance” under the Narcotics Drugs & Psychotropic Substances (NDPS) Act 1985 by Narcotics Control Bureau, India
  • Usage in Pharmaceutical, Agrochemical, Dyes & Pigments, Cellulose Acetate Production
slide40

Applications & End Usage-Acetic Anhydride

*IOLCP is installing the Manufacturing Plant of Acetyl Chloride with the Capacity of 5200 TPA.

slide44

Acetic Anhydride - Market Share

Domestic Market

Global Market

Indian Market

55,000 MT per Annum

Global Market

2,00,000 MT per Annum

upcoming projects mca acetyl chloride
1.Producing MCA without using hydrogenation.

2. MCA Plant is equipped with bubble cap graphite

distillation Column instead of packed column.

3. Plant is equipped with Scrubbing System to take

care of Environment Aspects.

4. In the Plant 900 critical parameters controlled by

DCS for maintaining product quality and quantity

Upcoming ProjectsMCA & Acetyl Chloride
contd
5.Plant is based on forward and backward integration of existing products.

6.Acetyl Chloride is manufactured with HCL root instead of other root to reduce its cost and byproduct.

7.Process Parameters are designed using Simulation Software “CHEMCAD” Supplied by Chemstations USA.

8.Equipped with Teflon coated pipe and fitting to minimize maintenance problem.

Contd..
iso butyl benzene
1.IBB Plant is equipped with

Pneumatic transfer System

instead of pumps to save

power.

2.In the Plant 1400 Critical

parameters controlled by

DCS to maintain product quality and Yield.

3.In the Plant Air Compressors are equipped with

Variable Frequency toget Energy Efficiency.

4. IBB Plant is the Backward integration of existing

product of IOLCP.

Iso Butyl Benzene
upcoming diversification plans anti ulcerants proton pump inhibitors ppi s
The company has planned for installation of new manufacturing facilities of PPIs- i.e. Rabiprazole, Omeprazole, Esomeprazole, Lansoprazole & Pantoprazole .

Rabiprazole is used to treat conditions where the stomach produces too much acid, including ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.

The total amount of Capital Expenditure will be about Rs 100 Crores ( approx USD 20.83 million).

The Project of Rabiprazole is planned to be implemented from 2009-10.

Upcoming Diversification PlansAnti-ulcerants- Proton Pump Inhibitors (PPI’s)
slide51

Proton Pump Inhibitors (PPIs)

  • Bind to Proton Pump and Prevent it from Producing Acid in to the Stomach.
  • Usage in Treatment of Variety of Gastric Ailments.
  • Generally have More Potent Effect on Suppressing Acid than H-2 Blockers ( like Ranitidine, Cimetidine, Nizatidine ).
  • PPI’s Available :

- Rabeprazole

- Lansoprazole

- Omeprazole

- Pantoprazole

- Esomeprazole

comparison of ppis and antacids
Comparison of PPIs and Antacids

Ref: www.medscape.com/viewarticle/464898

comparison of ppis and h 2 blockers
Comparison of PPIs and H-2 Blockers

1.Am J Gastroenterol. 2000 Apr;95(4):936-42; 2. Dig Dis Sci. 2001 Mar;46(3):587-96

3. ISSN 1007-9327 CN 14-1219/R World J Gastroenterol 2005 July 14;11(26):4067-4077

global scenario of ppis
Global Scenario of PPIs

Capacity In MT

Years

slide57

Growth Potential

  • Potential for growth of these products is demonstrated by their growing usage in various industries.
  • While the demand growth is being accompanied by an increase in production capacities, there is still a significant projected demand – supply gap for these products in the market.
  • Ethanol, major raw material, available in abundance from Distilleries of Punjab & UP.
  • Company’s markets for these products are being significantly enhanced with the commencement of Indian Oil’s Refinery nearby at Panipat & from another upcoming HPCL-Mittal Refinery nearby at Bhatinda
slide60

Recognition

Awarded with “2nd National Energy Conservation Award”

Consecutively for the Years 2005, 2006,2007 & 2008

By Ministry of Power, Government of India

slide61

Commitment to Quality

  • The Company is committed to utilizing state-of-the- art and globally competitive technology in its manufacturing and processing facilities.
  • High Quality Products with Quality Checks at each and every stage, starting from Raw Material to Finished products with latest Technology Instruments.
certifications
Certificate of Pharmaceuticals Product-WHO for Ibuprofen.

Certificate of Foreign Drug Manufacturer from Japan.

Koshar Certificate for all finished products

Halal Committee Registration Certificate for Finished products

ISO 9001:2008 for Quality Management System

ISO 14001:2004 for Environmental Management System

Certificate for Foreign Trade Policy-STAR EXPORT HOUSE

Certifications
corporate ethics
The company believes that adherence to the corporate ethics and transparent working results in substantial and sustainable improvements in the performance. The Company has adopted the following practices :

Code of Corporate Governance & Conduct

Code to Prevent the Insider Trading

Code of Corporate Disclosure of Insider Trading

Whistle Blower Policy

Corporate Ethics
slide64

Process Automation Distribution Control Based Operations

  • Complete Automation of Process
  • Computerized Parameter recording
  • Better control of Process Parameters
  • - Operations on single mouse click
slide65

Our Technical Specializations

REACTION

SEPARATION

DISTILLATION

slide66

Research & Development

  • Equipped with latest infrastructure
  • Highly competent research team
  • Manufacturing technology for all the products developed in-house
  • Capacity to produce single to multi-kilogram quantities of organic compounds
  • Pilot plant studies for new products / molecules
  • ChemCAD (Simulation Software)
slide67

Energy Saving Measures

  • Energy Conservation - Major Emphasis Area
  • The most cost effective way for sustainable energy development is by improving end-use efficiency.
  • We Utilize Waste Process Energy to produce 660 TR/Day of Chilled Water generated through VAM Machines.
slide68

Environment Friendly Plant

Untreated Effluent Treated Effluent Standard

pH 4.0 - 5.0 7.0 – 8.0 7.0 - 8.0

TDS (mg/L) 2100 - 2500 1600 - 1800 <2100

BOD(mg/L) 10000 - 12000 20 - 30 < 30

COD (mg/L) 14000 - 18000 175 - 200 < 250

slide69

Contact Us

Head Office 85 , Industrial Area ‘A’

Ludhiana- 141003 India

Tele +91-161-2225531-35

Fax +91-161-2608784 , 2226929

Works: Village Fatehgarh Channa

Mansa Road Barnala-148101

Tele +91-1679-285285-88

Fax +91-1679-285292

Contact Persons Mr Varinder Gupta

varindergupta@iolcp.com

Mr. Rakesh Mahajan

rakeshmahajan@iolcp.com

Mr. R.K.Thukral

rkthukral@iolcp.com

Website : www.iolcp.com